Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
13.23
-1.15 (-8.00%)
At close: Apr 1, 2025, 4:00 PM
13.21
-0.02 (-0.14%)
After-hours: Apr 1, 2025, 6:26 PM EDT

Centessa Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-235.76-151.09-216.21-381.9-10.66
Upgrade
Depreciation & Amortization
0.340.310.130.03-
Upgrade
Other Amortization
0.60.5---
Upgrade
Asset Writedown & Restructuring Costs
---220.45-
Upgrade
Stock-Based Compensation
33.5529.3924.9714.850.34
Upgrade
Other Operating Activities
37.05-20.63-6.7816.430.24
Upgrade
Change in Accounts Payable
-4.59-2.726.353.8-0.05
Upgrade
Change in Other Net Operating Assets
26.75-16.11-9.01-9.83-0.5
Upgrade
Operating Cash Flow
-142.06-160.34-200.55-136.16-10.63
Upgrade
Capital Expenditures
-0.03-0.17-1.14-0.19-
Upgrade
Cash Acquisitions
---63.44-
Upgrade
Investment in Securities
31.3-126.84---
Upgrade
Other Investing Activities
--0.21--
Upgrade
Investing Cash Flow
31.27-127-0.9363.26-
Upgrade
Long-Term Debt Issued
109.34--73.931.36
Upgrade
Long-Term Debt Repaid
-110.1----
Upgrade
Net Debt Issued (Repaid)
-0.76--73.931.36
Upgrade
Issuance of Common Stock
370.8321.120.72344.92-
Upgrade
Other Financing Activities
-5.32--0.26-0.30
Upgrade
Financing Cash Flow
364.7521.120.46660.151.36
Upgrade
Foreign Exchange Rate Adjustments
1.230.62-0.421.9-0.08
Upgrade
Net Cash Flow
255.19-265.61-201.44589.15-9.34
Upgrade
Free Cash Flow
-142.09-160.51-201.68-136.34-10.63
Upgrade
Free Cash Flow Margin
--2342.20%---
Upgrade
Free Cash Flow Per Share
-1.24-1.67-2.16-1.81-0.71
Upgrade
Cash Interest Paid
10.099.917.281.48-
Upgrade
Cash Income Tax Paid
0.082.941.3--
Upgrade
Levered Free Cash Flow
-75.19-96.6-108.73-82.08-
Upgrade
Unlevered Free Cash Flow
-68.88-90.41-104.18-80.49-
Upgrade
Change in Net Working Capital
-22.3213.39-3.298.11-
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q